Internal Medicine, Rheumatology · Los Angeles, CA
NPI
1952321101
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
200 Medical Plaza, #365,530,420,120
Los Angeles, CA, 90095
Phone (310) 828-7172
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
741 services
Medicare patients, 2024
193
Average age 71
Drug cost, 2024
$1.7M
1,650 prescriptions
Company payments, 2025
$3,177
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mihaela B Taylor was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 214 times for 133 patients. In total Mihaela B Taylor billed 741 services in 13 codes, and Medicare paid $47K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-25.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 214 | 133 | $13.41 | $2,871 |
| 99215 Office E&M - Established | Facility | 173 | 103 | $113.76 | $20K |
| 99214 Office E&M - Established | Facility | 117 | 96 | $75.44 | $8,827 |
| 99443 Telephone Services | Facility | 46 | 31 | $77.77 | $3,577 |
| 99213 Office E&M - Established | Facility | 46 | 30 | $53.36 | $2,454 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 40 | 36 | $13.74 | $550 |
| 20610 Joint Injection | Facility | 31 | 11 | $53.78 | $1,667 |
| 99215 Office E&M - Established | Office | 25 | 23 | $142.45 | $3,561 |
| 99214 Office E&M - Established | Office | 21 | 20 | $109.41 | $2,298 |
By year: 2022 $75K for 884 services; 2023 $74K for 831 services; 2024 $47K for 741 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mihaela B Taylor prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 302 prescriptions and refills. In total Mihaela B Taylor wrote 1,650 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 302 | 615 | 94 | $11K |
| Gabapentin Generic | 170 | 395 | 58 | $2,612 |
| Prednisone Generic | 89 | 146 | 35 | $990 |
| Duloxetine Hcl Generic | 85 | 181 | 23 | $3,479 |
| Leflunomide Generic | 68 | 116 | 16 | $2,540 |
| Cyclobenzaprine Hcl Generic | 64 | 108 | 17 | $822 |
| Celecoxib Generic | 60 | 88 | 17 | $1,128 |
| Pregabalin Generic | 52 | 74 | 16 | $1,187 |
| Otezla Apremilast | 49 | 55 | Under 11 | $262K |
| Sulfasalazine Dr Sulfasalazine | 44 | 80 | 18 | $1,702 |
| Orencia Abatacept | 40 | 47 | Under 11 | $254K |
| Tramadol Hcl Generic | 40 | 40 | Under 11 | $174 |
| Sulfasalazine Generic | 38 | 68 | 11 | $1,305 |
| Folic Acid Generic | 35 | 91 | 12 | $240 |
| Plaquenil Hydroxychloroquine Sulfate | 30 | 52 | Under 11 | $22K |
Brand drugs: 411 claims; generic drugs: 1,239 claims; opioid claims: 51.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mihaela B Taylor $3,177 ($3,177 in general payments such as food, travel and fees) from 4 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $2,836.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.